press release details

Press Releases

Lam Research Corporation Reports Financial Results for the Quarter Ended June 29, 2014

View PDF

FREMONT, CA -- (Marketwired) -- 07/30/14 -- Lam Research Corp.(NASDAQ: LRCX) today announced financial results for the quarter ended June 29, 2014.

Highlights for the June 2014 quarter were as follows:

  • Revenue of $1,249 million, up 2% from the prior quarter 
  • GAAP gross margin of 44.6%, GAAP operating margin of 17.3% and GAAP diluted EPS of $1.35 
  • Non-GAAP gross margin of 46.4%, non-GAAP operating margin of 20.6%, and non-GAAP diluted EPS of $1.25  
  
Financial Highlights for the Quarters Ended June 29, 2014 and March 30, 2014 
(in thousands, except per-share data and percentages) 
          
U.S. GAAP 
  June 2014  March 2014  Change Q/Q 
            
Revenue $1,248,797  $1,227,392  +2%
Gross margin as percentage of revenue  44.6%  43.2% +140bps 
Operating margin as percentage of revenue  17.3%  15.6% +170 bps 
Diluted EPS $1.35  $0.96  +41%
            
Non-GAAP 
   June 2014   March 2014  Change Q/Q 
            
Revenue $1,248,797  $1,227,392  +2%
Gross margin as percentage of revenue  46.4%  45.5% +90 bps 
Operating margin as percentage of revenue  20.6%  20.2% +40 bps 
Diluted EPS $1.25  $1.26  -1%
            
 

GAAP Financial Results
Revenue for the period was $1,249 million, gross margin was $557.0 million, or 44.6% of revenue, operating expenses were $341.2 million, operating margin was 17.3% of revenue, and net income was $233.4 million, or $1.35 per diluted share on a GAAP basis. This compares to revenue of $1,227 million, gross margin of $530.8 million, or 43.2% of revenue, operating expenses of $338.9 million, operating margin of 15.6% of revenue, and net income of $164.4 million, or $0.96 per diluted share, for the March 2014 quarter. Our June 2014 results benefited from an $83 million gain on sale of non-essential real estate.

Non-GAAP Financial Results
Non-GAAP gross margin was $579.9 million or 46.4% of revenue, non-GAAP operating expenses were $322.2 million, non-GAAP operating margin was 20.6% of revenue, and non-GAAP net income was $217.2 million, or $1.25 per diluted share. This compares to non-GAAP gross margin of $558.9 million or 45.5% of revenue, non-GAAP operating expenses of $311.0 million, non-GAAP operating margin of 20.2% of revenue, and non-GAAP net income of $216.4 million, or $1.26 per diluted share for the March 2014 quarter.

"Lam's June quarter and fiscal year results demonstrate strong execution of our growth strategy during a transformative period for the Company," stated Martin Anstice, Lam Research's president and chief executive officer. "­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Fiscal year results included record revenues in each successive quarter and operating income more than doubled year-over-year. Central to our financial and operational outperformance is our close collaboration with our customers in addressing the technical and economic challenges of scaling. We believe these efforts provide opportunities to build upon this foundation with market growth and share gains at the key inflections that will drive wafer fab equipment investment for the foreseeable future." 

Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investment balances increased to $3.2 billion at the end of the June 2014 quarter compared to $2.9 billion at the end of the March 2014 quarter. This increase was primarily the result of approximately $246 million in cash flows from operating activities and approximately $135 million of cash proceeds on sale of assets during the June 2014 quarter and was partially offset by approximately $42 million of capital expenditures and approximately $40 million of stock repurchases.

Deferred revenue and deferred profit balances at the end of the June 2014 quarter decreased to $361.6 million and $235.9 million, respectively, as compared to $431.5 million and $257.3 million, respectively, at the end of the March 2014 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $34.0 million as of June 29, 2014.

Geographic Distribution
The geographic distribution of shipments and revenue during the June 2014 quarter is shown in the following table:

       
Region Shipments  Revenue 
United States 23% 18%
Europe 7% 6%
Japan 14% 14%
Korea 25% 28%
Taiwan 18% 20%
Southeast Asia 4% 3%
China 9% 11%
       
 

Outlook
For the September 2014 quarter, Lam is providing the following guidance: 

         
  GAAPReconciling ItemsNon-GAAP
Shipments $1.11 Billion+/-$50 Million-$1.11 Billion+/-$50 Million
Revenue $1.15 Billion+/-$50 Million-$1.15 Billion+/-$50 Million
Gross margin 43.7%+/-1%$21 Million45.5%+/-1%
Operating margin 14.3%+/-1%$37 Million17.5%+/-1%
Earnings per share $0.71+/-$0.07$38 Million$0.92+/-$0.07
Diluted share count 177 Million 177 Million
     
 

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin - amortization related to intangible assets acquired in the Novellus transaction, $21 million.
  • Operating margin - amortization related to intangible assets acquired in the Novellus transaction, $37 million.
  • Earnings per share - amortization related to intangible assets acquired in the Novellus transaction, $37 million; the amortization of convertible note discounts, $8 million; and the associated tax benefit for non-GAAP items ($7) million, totaling $38 million.

Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2014 and March 2014 quarters exclude rationalization of certain product configurations, amortization related to intangible assets acquired in the Novellus transaction, the amortization of convertible note discounts, and tax expense (benefit) of non-GAAP items. Additionally, the June 2014 quarter non-GAAP results exclude the release of acquisition-related inventory fair value impacts, restructuring charges, cost associated with the disposition of business, gain on sale of real estate, and tax benefit on successful resolution of certain tax matters. The March 2014 quarter non-GAAP results also exclude the impairment of a long-lived asset and expenses associated with the synthetic lease impairment.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's web site at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers, our ability to continue to successfully execute our growth strategy during transformative periods, our ability to continue to successfully collaborate closely with customers, our ability to address the technical and economic challenges of scaling, our ability to achieve market growth and share gains at key inflections, our ability to obtain and maintain market share in wafer fab equipment investment, our ability to deliver growth and value for our customers and our shareholders, and our guidance for shipments, revenue, gross margin, operating margin, and earnings per share. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 30, 2013 and Forms 10-Q for the three months ended September 29, 2013, December 29, 2013 and March 30, 2014. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research
Lam Research Corp.(NASDAQ: LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading etch, deposition, strip, and wafer cleaning solutions help customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, and more power-efficient chips. Through collaboration, continuous innovation and delivering on commitments, Lam is transforming atomic-scale engineering and enabling our customers to shape the future of technology. Based in Fremont, Calif., Lam Research is an S&P 500 ® company whose common stock trades on the NASDAQ Global Select Market under the symbol LRCX. For more information, please visit http://www.lamresearch.com.

  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(in thousands, except per share data and percentages) 
                
  Three Months Ended  Twelve Months Ended 
  June 29,  March 30,  June 30,  June 29,  June 30, 
  2014  2014  2013  2014  2013 
  (unaudited)  (unaudited)  (unaudited)  (unaudited)  (1) 
Revenue $1,248,797  $1,227,392  $986,214  $4,607,309  $3,598,916 
                     
 Cost of goods sold  691,761   696,594   572,287   2,599,828   2,195,857 
  Gross margin  557,036   530,798   413,927   2,007,481   1,403,059 
  Gross margin as a percent of revenue  44.6%  43.2%  42.0%  43.6%  39.0%
Research and development  185,449   185,978   180,220   716,471   683,688 
Selling, general and administrative  155,737   152,883   147,209   613,341   601,300 
  Total operating expenses  341,186   338,861   327,429   1,329,812   1,284,988 
  Operating income  215,850   191,937   86,498   677,669   118,071 
  Operating margin as a percent of revenue  17.3%  15.6%  8.8%  14.7%  3.3%
Gain on sale of real estate  83,090   -   -   83,090   - 
Other expense, net  (9,442)  (9,855)  (12,251)  (37,396)  (51,413)
  Income (loss) before income taxes  289,498   182,082   74,247   723,363   66,658 
Income tax expense (benefit)  56,103   17,686   (11,460)  91,074   (47,221)
  Net income $233,395  $164,396  $85,707  $632,289  $113,879 
Net income per share:                    
 Basic net income per share $1.44  $1.01  $0.53  $3.84  $0.67 
 Diluted net income per share $1.35  $0.96  $0.50  $3.62  $0.66 
Number of shares used in per share calculations:                    
 Basic  162,215   162,238   162,520   164,741   168,932 
 Diluted  173,345   171,636   169,722   174,503   173,430 
Cash dividend declared per share $0.18  $-  $-  $0.18  $- 
                     
(1) Derived from audited financial statements 
                     
 
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
       
  June 29, March 30, June 30,
  2014 2014 2013
  (unaudited) (unaudited) (1)
ASSETS         
Cash and cash equivalents $1,452,677 $1,292,301 $1,162,473
Short-term investments  1,612,967  1,462,171  1,334,745
Accounts receivable, net  800,616  818,390  602,624
Inventories  740,503  717,356  559,317
Other current assets  176,899  157,131  134,670
 Total current assets  4,783,662  4,447,349  3,793,829
Property and equipment, net  543,496  552,591  603,910
Restricted cash and investments  146,492  143,914  166,536
Goodwill and intangible assets  2,360,303  2,408,913  2,526,541
Other assets  159,353  154,600  159,499
 Total assets $7,993,306 $7,707,367 $7,250,315
          
LIABILITIES AND STOCKHOLDERS' EQUITY         
Current liabilities $1,582,001 $1,542,705 $1,404,475
          
Long-term debt and capital leases $817,202 $810,688 $789,256
Income taxes payable  258,357  251,080  246,479
Other long-term liabilities  122,662  111,346  134,313
 Total liabilities $2,780,222 $2,715,819 $2,574,523
          
Senior convertible notes  183,349  184,256  186,920
          
Stockholders' equity (2)  5,029,735  4,807,292  4,488,872
 Total liabilities and stockholders' equity $7,993,306 $7,707,367 $7,250,315
          
(1) Derived from audited financial statements
 
(2) Common shares issued and outstanding were 162,350 as of June 29, 2014, 161,988 shares as of March 30, 2014, and 162,873 shares as of June 30, 2013.
 
  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(in thousands) 
                
  Three Months Ended  Twelve Months Ended 
  June 29,  March 30,  June 30,  June 29,  June 30, 
  2014  2014  2013  2014  2013 
  (unaudited)  (unaudited)  (unaudited)  (unaudited)  (1) 
CASH FLOWS FROM OPERATING ACTIVITIES:                    
Net income $233,395  $164,396  $85,707  $632,289  $113,879 
Adjustments to reconcile net income to net cash providedby operating activities:                    
 Depreciation and amortization  71,115   73,256   76,051   292,254   304,116 
 Deferred income taxes  (4,104)  (816)  (22,884)  7,537   (70,155)
 Impairment of long-lived assets  -   4,000   -   11,632   - 
 Equity-based compensation expense  33,085   24,334   25,241   103,700   99,330 
 Impairment of investment  -   -   -   -   3,711 
 Income tax benefit on equity-based compensation plans  6,269   (296)  364   5,973   (483)
 Excess tax benefit on equity-based compensation plans  (6,361)  296   (364)  (6,065)  539 
 Amortization of convertible note discount  8,411   8,313   8,028   33,063   31,558 
 Gain on sale of real estate  (83,090)  -   -   (83,090)  - 
 Other, net  8,241   2,741   5,342   12,669   37,201 
 Changes in operating asset and liabilities:  (21,070)  13,986   (2,497)  (292,913)  200,237 
  Net cash provided by operating activities  245,891   290,210   174,988   717,049   719,933 
                     
CASH FLOWS FROM INVESTING ACTIVITIES:                    
Capital expenditures and intangible assets  (41,764)  (41,638)  (43,140)  (145,503)  (160,795)
Cash paid for business acquisition  (11,839)  -   (800)  (30,227)  (9,916)
Net purchases of available-for-sale securities  (155,035)  (82,744)  (6,442)  (283,966)  (58,405)
(Issuance) repayments of notes receivable  -   -   (10,000)  10,000   (10,000)
Proceeds from sale of assets  134,762   -   -   156,397   660 
Transfer of restricted cash and investments  (637)  28,572   (328)  28,085   (181)
  Net cash used for investing activities  (74,513)  (95,810)  (60,710)  (265,214)  (238,637)
                     
CASH FLOWS FROM FINANCING ACTIVITIES:                    
Principal payments on long-term debt and capital lease obligations  (739)  (112)  (698)  (1,658)  (2,234)
Excess tax benefit on equity-based compensation plans  6,361   (296)  364   6,065   (539)
Treasury stock purchases  (40,249)  (52,415)  (2,275)  (244,859)  (955,661)
Reissuances of treasury stock related to employee stock purchase plan  14,597   13,210   12,846   42,926   31,265 
Proceeds from issuance of common stock  8,657   5,111   16,713   34,791   39,379 
  Net cash provided by (used for) financing activities  (11,373)  (34,502)  26,950   (162,735)  (887,790)
Effect of exchange rate changes on cash  371   (152)  2,136   1,104   4,215 
Net increase (decrease) in cash and cash equivalents  160,376   159,746   143,364   290,204   (402,279)
Cash and cash equivalents at beginning of period  1,292,301   1,132,555   1,019,109   1,162,473   1,564,752 
Cash and cash equivalents at end of period $1,452,677  $1,292,301  $1,162,473  $1,452,677  $1,162,473 
                     
(1) Derived from audited financial statements 
  
 
  
Non-GAAP Financial Summary 
(in thousands, except percentages and per share data) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 29,  March 30, 
  2014  2014 
         
Revenue $1,248,797  $1,227,392 
Gross margin $579,888  $558,881 
Gross margin as percentage of revenue  46.4%  45.5%
Operating expenses $322,155  $311,046 
Operating income $257,733  $247,835 
Operating margin as a percentage of revenue  20.6%  20.2%
Net income $217,228  $216,384 
Net income per diluted share $1.25  $1.26 
Shares used in per share calculation - diluted  173,345   171,636 
         
 
  
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income 
(in thousands, except per share data) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 29,  March 30, 
  2014  2014 
U.S. GAAP net income $233,395  $164,396 
Pre-tax non-GAAP items:        
 Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold  21,685   21,670 
 Costs associated with rationalization of certain product configurations - cost of goods sold  -   4,855 
 Acquisition-related inventory fair value impact - cost of goods sold  1,167   - 
 Synthetic lease impairment - cost of goods sold  -   1,558 
 Amortization related to intangible assets acquired in Novellus transaction - operating expenses  16,547   16,537 
 Restructuring charges - operating expenses  295   - 
 Costs associated with rationalization of certain product configurations - operating expenses  1,086   1,922 
 Cost associated with disposition of business - operating expense  1,103   - 
 Impairment of long lived asset - operating expense  -   4,000 
 Synthetic lease impairment - operating expense  -   5,356 
 Amortization of convertible note discount, Lam notes - other expense, net  7,504   7,416 
 Amortization of convertible note discount, Novellus assumed notes - other expense, net  763   999 
 Gain on sale of real estate  (83,090)  - 
Net tax expense (benefit) on non-GAAP items  17,075   (12,325)
Net income tax benefit on sucessful resolution of certain tax matters  (302)  - 
Non-GAAP net income $217,228  $216,384 
Non-GAAP net income per diluted share $1.25  $1.26 
Number of shares used for diluted per share calculation  173,345   171,636 
         
 

 

       
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income 
(in thousands, except percentages) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 29,  March 30, 
  2014  2014 
U.S. GAAP gross margin $557,036  $530,798 
Pre-tax non-GAAP items:        
 Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold  21,685   21,670 
 Costs associated with rationalization of certain product configurations - cost of goods sold  -   4,855 
 Acquisition-related inventory fair value impact - cost of goods sold  1,167   - 
 Synthetic lease impairment - cost of goods sold  -   1,558 
Non-GAAP gross margin $579,888  $558,881 
U.S. GAAP gross margin as a percentage of revenue  44.6%  43.2%
Non-GAAP gross margin as a percentage of revenue  46.4%  45.5%
U.S. GAAP operating expenses $341,186  $338,861 
Pre-tax non-GAAP items:        
 Amortization related to intangible assets acquired in Novellus transaction - operating expenses  (16,547)  (16,537)
 Restructuring charges - operating expenses  (295)  - 
 Costs associated with rationalization of certain product configurations - operating expenses  (1,086)  (1,922)
 Cost associated with disposition of business - operating expense  (1,103)  - 
 Impairment of long lived asset - operating expense  -   (4,000)
 Synthetic lease impairment - operating expense  -   (5,356)
Non-GAAP operating expenses $322,155  $311,046 
Non-GAAP operating income $257,733  $247,835 
Non-GAAP operating margin as a percent of revenue  20.6%  20.2%
 

Lam Research Corporation Contacts:
Carol Raeburn
Investor Relations
phone: 510-572-4450
e-mail: carol.raeburn@lamresearch.com

Source: Lam Research Corporation

 

News Provided by Acquire Media